NEA 15 GP, LLC's Net Worth

$814 Million

Who is NEA 15 GP, LLC?

NEA 15 GP, LLC has an estimated net worth of $814 Million. This is based on reported shares across multiple companies, which include Desktop Metal, Inc., Cascadian Therapeutics, Inc., Arcellx, Inc., Robinhood Markets, Inc., Nkarta, Inc., Berkshire Grey, Inc., AVEO PHARMACEUTICALS, INC., IonQ, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., Annexon, Inc., ARCA biopharma, Inc., Senti Biosciences, Inc.\, Achaogen Inc, Bright Health Group Inc., and ARDELYX, INC..

SEC CIK

NEA 15 GP, LLC's CIK is 0001640033

Past Insider Trading and Trends

2018 was NEA 15 GP, LLC's most active year for acquiring shares with 28 total transactions. NEA 15 GP, LLC's most active month to acquire stocks was the month of July. 2021 was NEA 15 GP, LLC's most active year for disposing of shares, totalling 25 transactions. NEA 15 GP, LLC's most active month to dispose stocks was the month of July. 2021 saw NEA 15 GP, LLC paying a total of $87,118,710.00 for 211,998,101 shares, this is the most they've acquired in one year. In 2019 NEA 15 GP, LLC cashed out on 6,662,532 shares for a total of $169,894,566.00, their largest year based on trade value.